1.
Emerg Infect Dis
; 27(12): 3178-3180, 2021 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34559045
RESUMO
In vitro determination of severe acute respiratory syndrome coronavirus 2 neutralizing antibodies induced in serum samples from recipients of the CoronaVac vaccine showed a short protection period against the original virus strain and limited protection against variants of concern. These data provide support for vaccine boosters, especially variants of concern circulate.